Clene, Inc. (CLNN)
4.435
+0.12
(+2.66%)
USD |
NASDAQ |
Aug 24, 16:00
4.435
0.00 (0.00%)
After-Hours: 20:00
Clene Total Liabilities (Quarterly) : 47.82M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 47.82M |
| March 31, 2026 | 40.47M |
| December 31, 2025 | 35.72M |
| September 30, 2025 | 34.67M |
| June 30, 2025 | 30.68M |
| March 31, 2025 | 30.29M |
| December 31, 2024 | 36.19M |
| September 30, 2024 | 35.69M |
| June 30, 2024 | 40.83M |
| March 31, 2024 | 40.80M |
| December 31, 2023 | 38.95M |
| September 30, 2023 | 39.03M |
| June 30, 2023 | 46.31M |
| March 31, 2023 | 41.52M |
| December 31, 2022 | 41.26M |
| September 30, 2022 | 45.32M |
| June 30, 2022 | 45.10M |
| Date | Value |
|---|---|
| March 31, 2022 | 51.34M |
| December 31, 2021 | 50.47M |
| September 30, 2021 | 67.35M |
| June 30, 2021 | 99.21M |
| March 31, 2021 | 94.61M |
| December 31, 2020 | 67.90M |
| September 30, 2020 | 21.12M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 43.78M |
| September 30, 2019 | 43.15M |
| June 30, 2019 | 42.47M |
| March 31, 2019 | 42.32M |
| December 31, 2018 | 42.16M |
| September 30, 2018 | 42.36M |
| June 30, 2018 | 0.247M |
| March 31, 2018 | 0.187M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.097M |
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Summit Therapeutics, Inc. | 122.20M |
| Kezar Life Sciences, Inc. | 2.762M |
| Protara Therapeutics, Inc. | 14.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.04M |
| Shareholders Equity (Quarterly) | -24.78M |
| Debt to Equity Ratio | -0.9018 |
| Current Ratio | 3.074 |
| Net Debt Paydown Yield | -0.36% |